Objective: The purpose of this study was to determine whether common single nucleotide polymorphisms (SNPs) at the adiponectin (ADIPOQ) locus influence changes in circulating adiponectin and the features of insulin resistance in response to a weight loss intervention. Subjects: In total, 294 nondiabetic/overweight-obese Koreans participated in a clinical intervention study lasting 12 weeks involving a caloric reduction of À300kcal/day. Methods: Plasma adiponectin, blood lipids, glucose and insulin concentrations were measured at baseline and after weight loss. Insulin resistance was estimated by homeostasis model assessment insulin resistance (HOMA-IR) derived from fasting glucose and insulin concentrations. We genotyped for three SNPs, 45T4G, 276G4T and À11377C4G. Results: At baseline, HOMA-IR was significantly higher in GG homozygotes than in carriers of the T allele at SNP276G4T of the adiponectin gene (Po0.05). With regard to SNP45T4G and SNP À11377C4G, we did not find any genotype related differences in baseline levels of HOMA-IR and adiponectin. In the 45/276 haplotype test, homozygous for the TG haplotype had significantly lower concentrations of plasma adiponectin (Po0.05). After the 12-week weight loss intervention, the significant decreases in HOMA-IR (Po0.001) and increases in adiponectin (Po0.01) were observed in GG homozygotes at SNP276, which were not shown in carriers of the T allele. Furthermore, there was a significant difference in the decreases in HOMA-IR between the GG homozygotes and carriers of the T allele at SNP276 (Po0.05). Regarding SNP45T4G and SNP À11377C4G, there was no association between SNP45T4G and SNP À11377C4G and decreases in HOMA-IR. In the 45/276 haplotype test, there was a significant difference in changes of adiponectin levels among those with different haplotype combinations (Po0.05). Conclusion: The SNP276G4T of the ADIPOQ gene is associated with different responses of circulating adiponectin and insulin resistance to mild weight loss in overweight-obese subjects.
Introduction
The epidemic of overweight and obesity has been termed 'globesity' to emphasize the global nature of the problem. Even traditionally 'lean' societies are beginning to experience the burdens associated with increasing prevalence of obesity. The prevalence of obesity in Korea continues to increase, such that nearly 30.6% of adults over the age of 20 years are now considered overweight-obese. 1 Numerous studies have reported that lifestyle modifications with a low-calorie diet can lead to weight loss and the concomitant improvement of many of the metabolic complications often associated with obesity, including insulin resistance. 2, 3 However, the factors responsible for the enhanced insulin sensitivity produced by weight loss are relatively unknown. One of these factors may be adiponectin, an insulin sensitizing and anti-inflammatory adipocytokine, synthesized primarily in the adipose tissue. Plasma levels of adiponectin are lower in obese subjects, and these low levels have been associated with insulin resistance (IR) 4, 5 as well as coronary artery disease (CAD). 6, 7 Weight loss that occurs either through hypocaloric diets 5 or gastric bypass surgery 8 has been shown to increase plasma adiponectin levels in men and women, 5, 8 resulting in decreases in IR.
There is also evidence in animals that the administration of adiponectin improves insulin sensitivity by inducing weight loss. 9 These lines of evidence support the concept that adiponectin may be a key mediator of weight loss-insulin sensitivity relationship. 10 A number of ADIPOQ single nucleotide polymorphisms (SNPs) and haplotypes have been associated with plasma adiponectin levels. 11 A synonymous SNP in exon 2 (45T4G)
has been inconsistently reported to be associated with type 2 diabetes. [10] [11] [12] Another SNP in intron 2 (276G4T), has been associated with IR as assessed by homeostasis model assessment insulin resistance (HOMA-IR) and reduced plasma adiponectin concentrations in Japanese. 12 Interestingly, the haplotype defined by two SNPs, 45T4G and 276G4T, was strongly associated with the metabolic syndrome and decreased plasma adiponectin levels in an Italian population. 13 Thus, genetic polymorphisms of the ADIPOQ gene that result in lower production and secretion of adiponectin may be partially responsible for the pathogenesis of the IR syndrome and diabetes. 14 However, it remains to be determined whether these SNPs of ADIPOQ gene might modulate the response of circulating adiponectin and other features of IR to weight loss. Therefore, we investigated whether variants of ADIPOQ gene could affect changes in circulating adiponectin levels and features of IR from a mild weight loss.
Subjects and methods

Study subjects
Study subjects were selected from participants of a nutritional genomic study conducted by the Clinical Nutrition Research Team at Yonsei University and meeting the following characteristics and inclusion criteria. All subjects had body mass index (BMI) greater than 23 kg/m 2 qualifying them as overweight or obese according to Asia-Pacific Guideline. 15 Subjects participated in 12-week low-calorie diet program designed to induce weight loss. Subjects were all nondiabetic and had normal results on echocardiograms. Subjects with orthopedic limitations, weight loss/gain over the previous 6 months or any diagnosis of diabetes, cardiovascular disease, liver disease, renal disease, thyroid or pituitary disease were excluded. Subjects taking any medications or nutrient-supplements were excluded. Two hundred and ninety four subjects (86 males and 208 females) completed the experimental intervention, whereas 26 participants discontinued the study due to personal reasons. All subjects gave their written informed consent to participate in this study, which was approved by the Institutional Review Board of Yonsei University.
Weight reduction protocol and energy intake This study was designed to achieve a minimal weight loss of 3% of initial body weight. During the study period, participants were subjected to calorie-restricted diets (approximately 300 kcal/day negative energy balance). At baseline, usual dietary intakes of subjects were assessed using a semiquantitative food frequency questionnaire and 24-h recall method. Based on the reported intakes of each subject, individualized and nutritionally balanced diets were planned. Subjects were allowed to select food substitute of equal caloric and nutrient composition. Subjects were instructed by trained dietitians and were also asked to keep the 3-day food records at each visit. 
Serum lipid profile
Fasting serum concentrations of total cholesterol and triglyceride (TG) were measured using commercially available kits on a Hitachi 7150 Autoanalyzer (Hitachi Ltd. Tokyo, Japan). After precipitation of serum chylomicron, lowdensity lipoprotein (LDL) and very low-density lipoprotein (VLDL) with dextran sulfate-magnesium, high-density lipoprotein (HDL) cholesterol was measured enzymatically. Low-density lipoprotein cholesterol was estimated indirectly using the Friedewald formula for subjects with serum TG concentrations o4.52 mol/l (400 mg/dl) and directly measured for subjects with serum TG concentration X4.52 mol/l.
Glucose, insulin and homeostasis model assessment insulin resistance Glucose was measured by a glucose oxidase method using the Beckman Glucose Analyzer (Beckman Instruments, Irvine, CA, USA). Insulin was measured by radioimmunoassays with commercial kits from Immuno Nucleo Corporation (Stillwater, MN, USA). Insulin resistance was estimated with ADIPOQ SNP276G4T, plasma adiponectin and insulin resistance in weight loss M-J Shin et al the HOMA-IR using the following equation: IR ¼ {fasting insulin (mU/ml) Â fasting glucose (mmol/l)}/22.5.
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Plasma adiponectin Plasma adiponectin concentrations were measured using an enzyme immunoassay (Human Adiponectin ELISA kit, B-Bridge International Inc., CA, USA). The resultant color reaction was read using a Victor 2 spectrophotometer (PerkinElmer life sciences, Turka, Finland) at 450 nm.
Statistical analysis
We used SPSS version 12.0 for Windows (Statistical Package for the Social Science, SPSS Ins., Chicago, IL, USA) for all statistical analyses. Each variable was examined for normality, and non-normally distributed variables were log-transformed. For descriptive purposes, mean values are presented on untransformed and unadjusted variables. Results are expressed as mean7s.e. In within-groups, we conducted paired t-tests for biochemical parameters at baseline and after caloric restriction. In between-groups, independent t-test was used to compare the differences in baseline values. Tests for Hardy-Weinberg equilibrium, SNPs 45-276 haplotype frequencies and standardized linkage disequilibrium (D 0 ) were determined by using Executive SNP analyzer (Istech, Ltd., Korea) with the expectation-maximization (EM) algorithm. Differences in continuous variables among haplotypes were evaluated by one-way ANOVA with bonferroni correction. A P-value of less than 0.05 was considered to be statistically significant.
Results
Detection of SNPs and frequency of the 45T4G, 276G4T and À11377C4G in the ADIPOQ gene Among the prescreened eight polymorphisms in the ADI-POQ gene, we found five rare nonsynonymous mutations (G-11391A at promoter region and H241P, Y111H, G90S, R221S at exon 3; allele frequency o2%) in healthy Koreans. Genotype distributions were in Hardy-Weinberg equilibrium with 54.8% TT, 36.0% TG and 9.2% GG at position 45, 49.3% GG, 40.5% GT and 10.2% TT at position 276 and 54.1% CC, 37.8% CG and 8.1% GG at position À11377. T was the major allele at position 45 (T frequency ¼ 0.728, P ¼ 0.157), G the major allele at position 276 (G frequency ¼ 0.692, P ¼ 0.628) and C the major allele at position À11377 (C frequency ¼ 0.73, P ¼ 0.558), respectively. The two SNPs of 45T4G and 276G4T of ADIPOQ gene were in linkage disequilibrium (D 0 ¼ À1, Po0.001), and there were estimated 45/276 haplotype frequencies of 16.3% for TG/TG, 28.0% for TG/TT, 23.2% for TG/GG, 10.4% for TT/TT, 13.1% for TT/ GG, and 9.0% for GG/GG. For subsequent statistical analyses, subjects were divided into three genotype subgroups: homozygous for the TG haplotype (TG/TG; n ¼ 48), heterozygous carriers of the TG haplotype (TG/X; n ¼ 151) and non-TG haplotype carriers (X/X; n ¼ 95).
Baseline characteristics of study population according to genotype As shown in Table 1 , there were no significant genotype related differences in age, sex distribution and BMI according to the SNP45T4G, 276G4T and À11377C4G. For the 45/ 276 haplotype, we did not observe any significant differences in age, sex distribution and BMI (data not shown).
Baseline serum lipid profiles, homeostasis model assessment insulin resistance and adiponectin levels according to genotype As shown in Table 2 , GG homozygotes at ADIPOQ SNP276G4T also had significantly lower concentrations of HDL-cholesterol (Po0.05) and significantly higher TG (Po0.01) than carriers of the T allele. HOMA-IR was significantly higher in GG homozygotes than in carriers of the T allele (Po0.05) at SNP276. Baseline circulating adiponectin levels were lower in GG homozygotes than in carriers of the T allele at SNP276. However, this difference was not statistically significant. Regarding SNP45T4G (Table 3 ) and SNP À11377C4G (Table 4) , we did not find any genotype related differences in baseline levels of lipid ADIPOQ SNP276G4T, plasma adiponectin and insulin resistance in weight loss M-J Shin et al cholesterol, LDL-cholesterol and TGs and significantly increased serum concentrations of HDL-cholesterol. For the 45/276 haplotype, we did not observe any significant differences in changes of blood lipid profiles after weight loss (data not shown).
Effect of 12-week caloric restriction on homeostasis model assessment insulin resistance and adiponectin according to genotype With caloric restriction, serum concentrations of glucose (Po0.05), insulin (Po0.001) and HOMA-IR (Po0.001) significantly decreased in GG homozygotes at SNP276, whereas these effects were not observed in carriers of the T allele. Plasma adiponectin concentrations significantly increased with a 12-week weight loss in GG homozygotes at SNP276 (Po0.01), whereas no significant changes in adiponectin were found in carriers of the T allele ( Figure 1 ). Furthermore, there was a significant difference in the decreases in HOMA-IR between the GG homozygotes and carriers of the T allele (Po0.05). Regarding SNP45T4G, there were significant decreases in HOMA-IR in both TT homozygotes and carriers of the G allele. Regarding SNP À11377C4G, there were significant decreases in HOMA-IR in both TT homozygotes and carriers of the G allele. In the 45/276 haplotype test, there was a significant difference in changes of adiponectin levels among those with different haplotype combinations (D values, TG/TG: 0.3870.19 mg/ml; TG/X: 0.2670.17 mg/ml; X/X: À0.3370.22 mg/ml; Po0.05).
Discussion
Recent studies have shown that increases in adiponectin levels with weight loss were significantly associated with the improvements in insulin sensitivity, suggesting that adiponectin may be a key molecules in the determination of the metabolic syndrome. 17, 18 Our results showed that changes in plasma adiponectin were inversely correlated with the changes in HOMA-IR, which was in agreement with previous findings. 19, 20 It has been reported that ADIPOQ 276G4T
genotypes had a strong association with IR and type 2 diabetes, which might be mediated through alterations in the expression levels of plasma adiponectin. 12 In the present study, the GG homozygotes had significantly higher degrees of IR than carriers of the T allele at ADIPOQ SNP276G4T.
The most striking finding in this study was the genotypespecific effect for changes in adiponectin concentrations and HOMA-IR following mild weight loss. Our results showed that plasma adiponectin concentrations increased after mild weight loss in GG homozygotes at the SNP276G4T of the ADIPOQ gene, which was not shown in carriers of the T allele. Furthermore, improvements in IR were also observed in GG homozygotes at SNP276. These results suggest that ADIPOQ SNP276G4T may be related to differential regulation of adiponectin synthesis in adipose tissue and that increases in adiponectin levels in GG homozygotes at SNP276 may contribute to the improvement in insulin sensitivity observed during mild weight loss. Moreover, our results support the recent finding of Thamer et al. 21 that insulin sensitivity is increased particularly in the subgroup with low adiponectin levels after a dietary intervention.
There is also evidence that lower baseline plasma adiponectin concentrations predicts greater increases in plasma adiponectin concentrations in response to weight loss. 19 In the present study, the levels of adiponectin after intervention were significantly increased in the GG homozygotes at ADIPOQ SNP276G4T who had the lower adiponectin levels at baseline. These results suggest that weight loss might have a beneficial effect on insulin sensitivity and could be of practical importance in GG homozygotes at ADIPOQ SNP276G4T with low baseline adiponectin levels. ADIPOQ SNP276G4T, plasma adiponectin and insulin resistance in weight loss M-J Shin et al
In contrast to previous study results, 12 dance of results may be explained by differences in ethnicity or specific study populations. Moreover, these results suggest that there may be a unique linkage disequilibrium structure or interactions of these SNPs with other genetic or environmental factors in Korean. Recently, we published on the association between 276G4T polymorphism of adiponectin gene and circulating adiponectin levels and HOMA-IR in 905 nondiabetic subjects. 26 Significantly lower adiponectin and higher HOMA-IR were reported in GG homozygotes at SNP276G4T compared to the carriers of the T allele. Furthermore, in accord with the current study, there were no significant genotype effects of SNP45T4G in that study. In summary, the GG homozygotes at SNP276 of the ADIPOQ gene is associated with significantly higher HOMA-IR than carriers of the T allele. Moreover, we observed the genotype-related differences in increases in adiponectin levels and decreases in HOMA-IR after weight loss at ADIPOQ SNP276G4T. These results suggest that SNP276G4T may be functional despite its presence in an intron. Alternatively, this SNP may be in strong linkage disequilibrium with unknown functional mutation. Data in the present study suggest that the GG homozygotes at ADIPOQ SNP276 have a beneficial effect on the improvement in IR after modest weight loss by modulation of circulating adiponectin levels. Further functional studies will be needed to establish whether these associations observed in our study are causal.
